These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of a clozapine rechallenge. Goates MG; Escobar JI J Clin Psychopharmacol; 1992 Apr; 12(2):139-40. PubMed ID: 1573039 [No Abstract] [Full Text] [Related]
8. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151 [TBL] [Abstract][Full Text] [Related]
9. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response. Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584 [TBL] [Abstract][Full Text] [Related]
10. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. Miller DD; Fleming F; Holman TL; Perry PJ J Clin Psychiatry; 1994 Sep; 55 Suppl B():117-21. PubMed ID: 7961554 [TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241 [TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports]. Vetter P; Proppe D; Hoppe-Seyler S Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422 [No Abstract] [Full Text] [Related]
13. The use of chloral hydrate and sodium amytal during clozapine initiation. Dickson RA; Williams R; Dalby JT Can J Psychiatry; 1994 Apr; 39(3):132-4. PubMed ID: 8033016 [TBL] [Abstract][Full Text] [Related]
14. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review. Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319 [TBL] [Abstract][Full Text] [Related]
15. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine. Litman RE; Su TP; Potter WZ; Hong WW; Pickar D Br J Psychiatry; 1996 May; 168(5):571-9. PubMed ID: 8733795 [TBL] [Abstract][Full Text] [Related]
18. Duration of a clozapine trial in neuroleptic-resistant schizophrenia. Meltzer HY Arch Gen Psychiatry; 1989 Jul; 46(7):672. PubMed ID: 2567591 [No Abstract] [Full Text] [Related]
19. Clozapine decreases smoking in patients with chronic schizophrenia. McEvoy J; Freudenreich O; McGee M; VanderZwaag C; Levin E; Rose J Biol Psychiatry; 1995 Apr; 37(8):550-2. PubMed ID: 7619979 [No Abstract] [Full Text] [Related]
20. [Quality of life of schizophrenic patients and clozapine]. Raoul Y; Manesse P; Delage M Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]